Caner Saygin, MD
Caner Saygin, MD
Assistant Professor of Medicine
Specialties
- Hematology and Oncology (Cancer)
Locations
- Chicago - Hyde Park
- About
- Specialties & Areas of Expertise
- Locations & Patient Information
- Education & Research
- Accepted Insurance
- External Professional Relationships
Caner Saygin, MD, is a board-certified oncologist who specializes in diagnosing and treating cancer in adults. With extensive training and experience in oncology, Dr. Saygin focuses primarily on patients with leukemia and blood disorders, including:
- Acute myeloid leukemia (AML)
- Acute lymphoblastic leukemia (ALL)
- Myelodysplastic syndromes (MDS)
- Chronic myeloid leukemia (CML)
- Chronic lymphocytic leukemia (CLL)
- Hairy cell leukemia (HCL)
- Large granular lymphocytic leukemia (LGL)
- Clonal hematopoiesis of indeterminate potential (CHIP)
- Clonal cytopenia of undetermined significance (CCUS)
He delivers individualized treatment plans and provides compassionate care for his patients. As a cancer expert, Dr. Saygin is dedicated to staying up-to-date on the latest advancements in cancer treatment, including newly emerging targeted therapies and immunotherapies. He is committed to helping his patients achieve the best possible outcomes in their cancer journey.
In addition to his clinical practice, Dr. Saygin is a physician-scientist who investigates the mechanisms of leukemia, including how leukemias evolve from healthy blood cells in the bone marrow. This work includes studies on clonal hematopoiesis of indeterminate potential (CHIP) and how CHIP progresses to acute leukemias. Dr. Saygin’s lab also focuses on developing new therapies for patients with leukemias, and he is passionate about translating his laboratory discoveries into clinical trials testing novel experimental therapies for leukemia patients. His research has been published in several, highly respected, peer-reviewed journals, such as Cell Stem Cell, Journal of Experimental Medicine, Leukemia, Clinical Cancer Research and Blood Advances. His clinical and laboratory studies have been funded by the Leukemia Lymphoma Society, American Society of Hematology, American Society of Clinical Oncology, Prevent Cancer Foundation and Cancer Research Foundation.
Board Certifications
- Hematology
- Medical Oncology
- Internal Medicine
Practicing Since
- 2017
Languages Spoken
- English
- Turkish
Medical Education
- Istanbul University
Internship
- Ohio State University
Residency
- The Ohio State University
Fellowship
- University of Chicago
News & Research
Insurance
- Aetna Better Health *see insurance page
- Aetna HMO (specialists only)
- Aetna Medicare Advantage HMO & PPO
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS Medicare Advantage HMO & PPO
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Choice HMO (specialists only)
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If you have questions regarding your insurance benefits at UChicago Medicine, please contact our financial counseling team at OPSFinancialCounseling@uchospitals.edu.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.